Oxaliplatin Ebewe 5mg/ml powder for infusion Malta - English - Medicines Authority

oxaliplatin ebewe 5mg/ml powder for infusion

ebewe pharma gmbh nfg. kg - oxaliplatin 5 mg/ml - powder for solution for infusion

Dacarbazine Medac 200 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

dacarbazine medac 200 mg

مستودع ادوية الرعاية الدوائية - pharma care drug store - dacarbazine 200 mg - 200 mg

Dacarbazine Medac 500mg 500 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

dacarbazine medac 500mg 500 mg

مستودع ادوية الرعاية الدوائية - pharma care drug store - dacarbazine 500 mg - 500 mg

Oxaliplatin Medac 50 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

oxaliplatin medac 50 mg

مستودع ادوية الرعاية الدوائية - pharma care drug store - oxaliplatin 50 mg - 50 mg

Oxaliplatin Medac 100 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

oxaliplatin medac 100 mg

مستودع ادوية الرعاية الدوائية - pharma care drug store - oxaliplatin 100 mg - 100 mg

Epirubicin ONCOtrade 2 mg/ml Injektionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

epirubicin oncotrade 2 mg/ml injektionslösung

Epimedac 2 mg/ml Injektionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

epimedac 2 mg/ml injektionslösung

Oxaliplatin 50 mg/10ml Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

oxaliplatin 50 mg/10ml

مستودع ادوية الصباغ - sabbagh drug store - oxaliplatin 50 mg/10ml - 50 mg/10ml

Oxaliplatin 100 mg/20ml Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

oxaliplatin 100 mg/20ml

مستودع ادوية الصباغ - sabbagh drug store - oxaliplatin 100 mg/20ml - 100 mg/20ml

Clopidogrel 1A Pharma European Union - English - EMA (European Medicines Agency)

clopidogrel 1a pharma

acino pharma gmbh  - clopidogrel - peripheral vascular diseases - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome:- non st segment elevation acute coronary syndrome (unstable angina or non q wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).- st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.for further information please refer to section 5.1.